LILLY ELI & CO (LLY)

Industry: Drugs
LLY
LILLY ELI & CO

Price: $37.68

Chaikin Power Gauge Report | Generated: Thu Jun 23 13:39 EDT 2011
$37.68

Power Gauge Rating

LLY - Very Bullish

The Chaikin Power Gauge Rating for LLY is very bullish due to very attractive financial metrics, very positive expert opinions and bullish price/volume activity. The rating also reflects weak earnings performance. LLY's financial metrics are excellent due to a high return on equity and low price to sales ratio.
TM

Financial Metrics

Earnings Performance

Price/Volume Activity

Expert Opinions

News Sentiment Rating

Neutral
LLY LILLY ELI & CO June 22, 2011

Chaikin Sentiment Gauge for LLY is neutral. Stories concerning LLY have a balanced or neutral sentiment.

TM

News Sentiment :Neutral

Power Trend - 5 Year Chart

The Power Gauge distills a 20 factor model into a concise picture of a stock's potential.

High Potential

Neutral

Low Potential

I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here

www.chaikinpowertools.com

Financials & Earnings

Financial Metrics

Financial Metrics Rating

LT Debt/Equity Ratio

Very Bullish
LLY's financial metrics are excellent. The company yields a high return on shareholder's equity and has high revenue per share. The rank is based on a high long term debt to equity ratio, high price to book value ratio, high return on equity, low price to sales ratio and relatively high cash flow.

Price to Book Value

Return on Equity

Price to Sales Ratio

Business Value

Assets and Liabilities

Ratio Current Ratio LT Debt/Equity TTM 2.01 0.55

Valuation
Ratio Price/Book Price/Sales TTM 3.13 1.89

Returns
Ratio Return on Invest Return on Equity TTM 28.5% 43.4%

Earnings Performance

Earnings Performance Rating

Earnings Growth

Bearish
LLY's earnings performance has been weak. The company is priced relatively high compared to next year's projected EPS and has an erratic 5 year earnings trend. The rank is based on high earnings growth over the past 3-5 years, a relatively high projected P/E ratio and inconsistent earnings over the past 5 years.

Earnings Surprise

Earnings Trend

Projected P/E Ratio

Earnings Consistency

5 Year Revenue and Earnings Growth

12/06 Revenue(M) Rev % Growth EPS EPS % Growth 15,691.00 7.14% $2.45 34.62% 12/07 18,633.50 18.75% $2.71 10.61% 12/08 20,378.00 9.36% $-1.89 -169.74% 12/09 21,836.00 7.15% $3.94 308.47% 12/10 23,076.00 5.68% $4.58 16.24%

EPS Estimates
Factor Quarterly EPS Yearly EPS Factor 3-5 year EPS Actual EPS Prev $1.22 $4.58 Actual EPS Growth 9.62% EST EPS Current $1.17 $4.27 Est EPS Growth -4.38% Change -0.05 -0.31 Change -14.00

EPS Surprise
Estimate Latest Qtr 1 Qtr Ago 2 Qtr Ago 3 Qtr Ago $1.17 $1.10 $1.15 $1.11 Actual $1.24 $1.11 $1.21 $1.24 Difference $0.07 $0.01 $0.06 $0.13 % Difference 5.98 0.91 5.22 11.71

EPS Quarterly Results

FY 12/09 12/10 12/11 Qtr 1 $1.20 $1.13 $0.95 Qtr 2 $1.06 $1.22 Qtr 3 $0.86 $1.18 Qtr 4 $0.83 $1.05 Total $3.95 $4.58 -

Fiscal Year End Month is December.

I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here

www.chaikinpowertools.com

Price Trend & Expert Opinions

Price/Volume Activity

Price/Volume Activity Rating

Relative Strength vs Market

Bullish
Price and volume activity for LLY is bullish. LLY has outperformed the S&P 500 over 26 weeks and has a rising price trend. The rank for LLY is based on its price strength versus the market, a positive Chaikin price trend and a negative Chaikin price trend ROC.

Chaikin Money Flow

Price Trend

Price Trend ROC

Volume Trend

Relative Strength vs S&P500 Index

Chaikin Money Flow

Chart shows whether LLY is performing better or worse than the market.

Chaikin Money Flow analyzes supply and demand for a company's stock.

Price Activity
Factor 52 Week High 52 Week Low % Change YTD Rel S&P 500 Value 39.15 33.12 5.37%

Price Activity
Factor % Change Price - 4 Weeks % Change Price - 24 Weeks % Change Price - 4 Wks Rel to S&P % Change Price - 24 Wks Rel to S&P Value -1.64% 8.34% 0.90% 7.45%

Volume Activity
Factor Average Volume 20 Days Average Volume 90 Days Chaikin Money Flow Persistency Value 6,527,498 7,134,977 58%

Expert Opinions

Expert Opinions

Earnings Estimate Revisions

Very Bullish
Expert opinions about LLY are very positive. Insiders are net buyers of LLY's stock and analysts's opinions on LLY have been more positive recently. The rank for LLY is based on analysts revising earnings estimates upward, a low short interest ratio, insiders purchasing stock, optimistic analyst opinions and price strength of the stock versus the Drugs industry group.

Short Interest

Insider Activity

Analyst Opinions

Relative Strength vs Industry

Earnings Estimate Revisions

Current Current Qtr Next Qtr 1.17 1.08 Current Current FY 4.27 7 Days Ago % Change 1.17 1.08 0.00% 0.00%

Analyst Recommendations
Factor Mean this Week Mean Last Week Change Mean 5 Weeks Ago Value Hold Hold 0.00 Hold

EPS Estimates Revision Summary

Last Week Up Curr Qtr Curr Yr Next Qtr 0 0 0 0 Down 0 0 0 0 Last 4 Weeks Up 0 1 0 1 Down 0 0 0 1

30 Days Ago % Change 4.27 0.00

Next Yr

I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here

www.chaikinpowertools.com

The Company & Its Competitors

LLY's Competitors in Drugs

Company LLY MRK JNJ NVS PFE GSK Power Gauge Historic EPS growth 9.62% 18.19% 4.21% 9.55% 6.66% 3.26% Projected EPS growth -4.38% 3.34% 6.03% 4.92% 3.06% 4.10% Profit Margin 20.82% 3.48% 19.77% 18.64% 12.51% 6.89% PEG -2.02 2.87 2.22 2.25 2.97 2.70 PE 7.85 10.10 13.71 11.84 9.09 14.24 Revenue(M) 23,076 45,987 61,587 50,624 67,809 45,905

News Headlines for LLY EU approves Lilly's weekly diabetes drug Bydureon - Jun 21, 2011 Lilly for Better Health Launches Enhanced Multi-Channel Patient Education Platform - Jun 14, 2011 Judge orders drug company to pay SC $327 million - Jun 3, 2011 Peregrine Appoints Jeffrey Masten as Vice President - May 31, 2011 Lilly USA, LLC Launches TruAssist for Patients May 16, 2011

Company Details LILLY ELI & CO LILLY CORPORATE CTR INDIANAPOLIS, IN 46285 USA Phone: 3172762000 Fax: 317-276-4878 Website: http://http://www.lilly.com Full Time Employees: 38,350 Sector: Medical

Company Profile Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Power Gauge Ratings are created using a relative ranking system that assigns a rank of 0 to 100 (100 being the highest) to each stock in the universe. Rank is calculated by evaluating each of the stocks factors and combining them into a single number using a weighting formula. A stock's rank ranges from 100-0, where 100 is the strongest, and a rank of 95 indicates the stock is better than 95% of the stocks in the universe. Chaikin Stock Research(CSR) is not registered as a securities broker dealer or investment advisor with either the U.S. Securities and Exchange Commission or with any state securities regulatory authority. CSR is not responsible for trades executed by users of this research report, our web site or mobile app based on the information included herein. The information presented in this report does not represent a recommendation to buy or sell stocks or any financial instrument nor is it intended as an endorsement of any security or investment. The information in this report is generic by nature and is not personalized to the specific financial situation of any individual. The user bears complete responsibility for their own investment research and should seek the advice of a qualified investment professional before making any investment decisions. Copyright (c) 1978-(Present) by ZACKS Investment Research, Inc ("ZACKS"). The information, data, analyses and opinions contained herein (1) includes the confidential and proprietary information of ZACKS, (2) may not be copied or redistributed, for any purpose, (3) does not constitute investment advice offered by ZACKS, (4) are provided solely for informational purposes, and (5) are not warranted or represented to be correct, complete, accurate or timely. ZACKS shall not be responsible for investment decisions, damages or other losses resulting from, or related to, use of this information, data, analyses or opinions. Past performance is no guarantee of future performance. ZACKS is not affiliated with Chaikin Power Tools. This report from Chaikin Power Tools is for informational purposes only and is not a recommendation to buy or sell securities.

LM 2.3 DS 3.0 LS 2.1

Data Provided by ZACKS Investment Research, Inc., www.zacks.com

Special offers to trade stocks from optionsXpress: www.chaikinpowertools.com